Taxanes and Capecitabine in Combination: Rationale and Clinical Results
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference40 articles.
1. Fluorinated pyrimidines: a new class of tumor-inhibitory compounds;Heidelberger;Nature,1957
2. Clinical pharmacology of 5-fluorouracil;Diasio;Clin Pharmacokinet,1989
3. The incorporation of 5-FU into RNA and its molecular consequences;Mandel;Prog Mol Subcell Biol,1969
4. Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate;Santi;Biochemistry,1974
5. Dihydropyrimidine dehydrogenase activity in human liver: population characteristics and clinical implication in 5-FU chemotherapy;Lu;Clin Pharmacol Thera,1995
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation;Clinical Cancer Research;2021-09-13
2. Phase II study of neo-adjuvant chemotherapy for locally advanced gastric cancer;BMJ Open Gastroenterology;2016-08
3. Taxanes;Anti-Cancer Drugs;2014-06
4. A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTere;Cancer Chemotherapy and Pharmacology;2014-02-23
5. Effect of the Weekly Administration of Liposome–Paclitaxel Combined with S-1 on Advanced Gastric Cancer;Japanese Journal of Clinical Oncology;2014-01-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3